Literature DB >> 9838

The effect of lorazepam on the vasoconstriction of fear.

M Johnstone.   

Abstract

Volume-pulse digital plethysmography performed under ideal conditions on relatively fit adults has shown that lorazepam 4 mg intravenously abolishes the vasoconstriction of fear and restores the digital vasodilatation of the tranquil mind. The sedative effect of the drug is prolonged and is associated with several hours of anterograde amnesia from the time of its administration. The drug has no effect on the vasoconstrictor reaction to cold, pain, noise or other forms of adrenergic stimuli. Lorazepam seems to modify or prevent the psychomotor reactions which may complicate ketamine anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9838     DOI: 10.1111/j.1365-2044.1976.tb11897.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  5 in total

1.  "Vasovagal" syncope.

Authors:  M Johnstone
Journal:  Br Med J       Date:  1976-10-23

Review 2.  Lorazepam: a review of its clinical pharmacological properties and therapeutic uses.

Authors:  B Ameer; D J Greenblatt
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

3.  Local warming and insertion of peripheral venous cannulas: single blinded prospective randomised controlled trial and single blinded randomised crossover trial.

Authors:  Rainer Lenhardt; Tanja Seybold; Oliver Kimberger; Brigitte Stoiser; Daniel I Sessler
Journal:  BMJ       Date:  2002-08-24

4.  Inhalation sedation - an adjunct to improved dental care: preliminary communication.

Authors:  A H Brook; E Major; M Winder; D S Berman
Journal:  J R Soc Med       Date:  1979-10       Impact factor: 18.000

5.  Infrared Vein Imaging for Insertion of Peripheral Intravenous Catheter for Patients Requiring Isolation for Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Nonrandomized Clinical Trial.

Authors:  Ziyun Zhang; Xia Wang; Lijuan Zhang; Xuejiao Lou; Xiaoyan Su; Xiping Wang; Fei Sun; Xifei He
Journal:  J Emerg Nurs       Date:  2021-10-12       Impact factor: 1.836

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.